Novo Nordisk
NVO
#105
Rank
NZ$330.98 B
Marketcap
NZ$75.08
Share price
2.39%
Change (1 day)
-15.41%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): NZ$40.11 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are NZ$51.43 Billion. In 2025 the company made an earning of NZ$37.81 Billion, an increase over its 2024 earnings that were of NZ$35.57 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$40.11 B6.08%
2025 NZ$37.81 B6.28%
2024 NZ$35.57 B28.01%
2023 NZ$27.79 B57.81%
2022 NZ$17.61 B5.24%
2021 NZ$16.73 B12.38%
2020 NZ$14.89 B13.11%
2019 NZ$13.16 B-3.45%
2018 NZ$13.63 B1.88%
2017 NZ$13.38 B4.3%
2016 NZ$12.83 B10.32%
2015 NZ$11.63 B7.47%
2014 NZ$10.82 B3.4%
2013 NZ$10.46 B19.09%
2012 NZ$8.78 B15.58%
2011 NZ$7.60 B16.58%
2010 NZ$6.52 B25.66%
2009 NZ$5.19 B10.68%
2008 NZ$4.69 B55.82%
2007 NZ$3.01 B7.02%
2006 NZ$2.81 B19.05%
2005 NZ$2.36 B10.55%
2004 NZ$2.13 B
2002 NZ$1.41 B-14.39%
2001 NZ$1.65 B-52.82%
2000 NZ$3.50 B250%
1999 NZ$1.00 B31.21%
1998 NZ$0.76 B34.31%
1997 NZ$0.56 B11.46%
1996 NZ$0.50 B9.03%
1995 NZ$0.46 B-3.15%
1994 NZ$0.48 B-0.67%
1993 NZ$0.48 B45.38%
1992 NZ$0.33 B-13.81%
1991 NZ$0.38 B37.12%
1990 NZ$0.28 B-0.79%
1989 NZ$0.28 B26.2%
1988 NZ$0.22 B24.97%
1987 NZ$0.18 B-0.9%
1986 NZ$0.18 B-7.78%
1985 NZ$0.19 B24.87%
1984 NZ$0.15 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.57 B-69.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$62.72 B 51.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$14.04 B-66.12%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$20.44 B-50.70%๐Ÿ‡บ๐Ÿ‡ธ USA